Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AURA Study: A Retrospective Non-interventional Study (NIS) to Assess the Effectiveness of Existing Anti vascUlar Endothelial Growth Factor (Anti VEGF) Treatment Regimens in Patients With Wet Age-related Macular Degeneration (wAMD)

NCT01447043 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT01447043
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01447043 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AURA Study: A Retrospective Non-interventional Study (NIS) to Assess the Effectiveness of Existing Anti vascUlar Endothelial Growth Factor (Anti VEGF) Treatment Regimens in Patients With Wet Age-related Macular Degeneration (wAMD)
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
January 31, 2009
Completion date
November 30, 2012
Enrollment
2,609 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

ophthalmology, macular degeneration